Abstract
We evaluated a new membrane dot immunobinding assay (CMV-CUBE; Difco Laboratories) for the detection of cytomegalovirus (CMV) antibody in marrow transplant patients and donors. The CMV-CUBE assay was compared with a commercially available enzyme immunoassay (EIA; CMV STAT) and a latex agglutination (LA; CMVScan) test. Serum samples were collected from 311 transplant patients and donors prior to transplantation. A total of 164 serum specimens were positive for CMV antibody by one or more of the three assays, with 153 of 164 samples (93.3%) positive by all three tests. A total of 147 serum specimens were CMV antibody negative. CMV-CUBE detected 154 of 164 (94%) of the positive samples, EIA detected 160 of 164 (97.5%), and LA detected 157 of 164 (95.7%) CMV-positive samples. Compared with EIA, CMV-CUBE had a sensitivity of 95.6% and a specificity of 99.3%. Compared with LA, CMV-CUBE had a sensitivity of 97.5% and a specificity of 99.4%. CMV-CUBE is a simple and rapid visual assay which can be used for the qualitative detection of antibody to CMV in patient serum.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adler S. P., McVoy M., Biro V. G., Britt W. J., Hider P., Marshall D. Detection of cytomegalovirus antibody with latex agglutination. J Clin Microbiol. 1985 Jul;22(1):68–70. doi: 10.1128/jcm.22.1.68-70.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beckwith D. G., Halstead D. C., Alpaugh K., Schweder A., Blount-Fronefield D. A., Toth K. Comparison of a latex agglutination test with five other methods for determining the presence of antibody against cytomegalovirus. J Clin Microbiol. 1985 Mar;21(3):328–331. doi: 10.1128/jcm.21.3.328-331.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bowden R. A., Sayers M., Flournoy N., Newton B., Banaji M., Thomas E. D., Meyers J. D. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med. 1986 Apr 17;314(16):1006–1010. doi: 10.1056/NEJM198604173141602. [DOI] [PubMed] [Google Scholar]
- Bowden R. A., Sayers M., Gleaves C. A., Banaji M., Newton B., Meyers J. D. Cytomegalovirus-seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks. Transfusion. 1987 Nov-Dec;27(6):478–481. doi: 10.1046/j.1537-2995.1987.27688071699.x. [DOI] [PubMed] [Google Scholar]
- Hursh D. A., Abbot A. D., Sun R., Iltis J. P., Rice D. H., Gleaves C. A. Evaluation of a latex particle agglutination assay for the detection of cytomegalovirus antibody in patient serum. J Clin Microbiol. 1989 Dec;27(12):2878–2879. doi: 10.1128/jcm.27.12.2878-2879.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leland D. S., Barth K. A., Cunningham E. B., Jansen J., Tricot G. J., French M. L. Evaluation of four methods for cytomegalovirus antibody detection for use by a bone marrow transplantation service. J Clin Microbiol. 1989 Jan;27(1):176–178. doi: 10.1128/jcm.27.1.176-178.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meyers J. D., Flournoy N., Thomas E. D. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis. 1986 Mar;153(3):478–488. doi: 10.1093/infdis/153.3.478. [DOI] [PubMed] [Google Scholar]
- Meyers J. D. Prevention and treatment of cytomegalovirus infection after marrow transplantation. Bone Marrow Transplant. 1988 Mar;3(2):95–104. [PubMed] [Google Scholar]